Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells
- 7 August 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 425 (2) , 109-116
- https://doi.org/10.1016/s0014-2999(01)01192-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factorEuropean Respiratory Journal, 2000
- Ligand‐induced differentiation of glucocorticoid receptor (GR) trans‐repression and transactivation: preferential targetting of NF‐κB and lack of I‐κB involvementBritish Journal of Pharmacology, 1999
- Efficacy of inhaled corticosteroids in asthmaJournal of Allergy and Clinical Immunology, 1998
- Golgi-disturbing agentsHistochemistry and Cell Biology, 1998
- Increased Vascular Endothelial Growth Factor Production in the Lungs of Rats with Hypoxia-induced Pulmonary HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Ovine Vascular Endothelial Growth Factor: Nucleotide Sequence and Expression in Fetal TissuesGrowth Factors, 1998
- Erratum to: BudesonideDrugs, 1992
- Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.Molecular Biology of the Cell, 1992
- Corticosteroid Inhibition of Airway Microvascular LeakageAmerican Review of Respiratory Disease, 1991
- Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.The Journal of Experimental Medicine, 1990